人乳头瘤病毒相关口咽癌治疗后的18F-氟脱氧葡萄糖正电子发射断层成像
该研究在澳大利亚布里斯班一家大型三级转诊中心,对2016至2018年接受治疗的口咽癌患者进行前瞻性队列分析(回顾性数据),共纳入224例患者,其中193例(86%)为HPV相关疾病。在该队列中,FDG-PET检测疾病复发的灵敏度为48.3%、特异度为72.6%、阳性预测值为23.7%、阴性预测值为88.8%。结论认为,与HPV非相关口咽癌相比,HPV相关口咽癌中FDG-PET的阳性预测值显著更低,解读治疗后阳性FDG-PET时应谨慎。
要点
- 224例口咽癌患者中193例(86%)为HPV相关疾病。
- FDG-PET检测复发的灵敏度48.3%、特异度72.6%、阳性预测值23.7%、阴性预测值88.8%。
- HPV相关口咽癌FDG-PET阳性预测值显著低于HPV非相关口咽癌。
核心结论
- HPV相关口咽癌中FDG-PET的阳性预测值显著低于HPV非相关口咽癌,解读治疗后阳性FDG-PET时应谨慎。
研究设计与样本
- 对2016至2018年接受治疗的口咽癌患者进行前瞻性队列分析(回顾性数据),研究在澳大利亚布里斯班一家大型三级转诊中心开展。
主要发现
- 共招募224例患者,其中193例(86%)为HPV相关疾病。
- 在该队列中,FDG-PET检测疾病复发的灵敏度为48.3%,特异度为72.6%,阳性预测值为23.7%,阴性预测值为88.8%。
关键数值与推荐
- FDG-PET检测疾病复发的灵敏度48.3%、特异度72.6%、阳性预测值23.7%、阴性预测值88.8%。
临床怎么用
- HPV相关口咽癌中FDG-PET的阳性预测值显著低于HPV非相关口咽癌,作者认为解读治疗后阳性FDG-PET时应谨慎。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Human papillomavirus association has changed the landscape of treatment for oropharyngeal squamous cell carcinoma; it remains to be seen whether current post-treatment surveillance schedules are effective. OBJECTIVE: Evaluate whether post-treatment surveillance of oropharyngeal cancer through FDG-PET imaging is modified by human papillomavirus association. METHODS: A prospective cohort analysis of retrospective data was conducted for patients undergoing treatment of oropharyngeal cancer between 2016 and 2018. This study was conducted at a single large tertiary referral center in Brisbane, Australia. RESULTS: Two-hundred and twenty-four patients were recruited for the purposes of the study, 193 (86%) with HPV-associated disease. In this cohort FDG-PET had a sensitivity of 48.3%, specificity of 72.6%, positive predictive value of 23.7%, and negative predictive value of 88.8% in detecting disease recurrence. CONCLUSIONS: FDG-PET in HPV-associated oropharyngeal cancer has significantly lower positive predictive value when compared to non-HPV-associated oropharyngeal cancer. Caution should be used when interpreting positive post-treatment FDG-PET.
引用
- Liu ZY, Khoo D, Hartel G, et al. Post-treatment 18F-fludeoxyglocuse-positron emission tomography in human papillomavirus-associated oropharyngeal cancer. Head Neck. 2023. PMID: 37306045. doi:10.1002/hed.27426
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。